GRENLOCH, N.J. - A.L. Hyde Co. has ended negotiations to buy Penn Fibre and Specialty Co. Inc., a privately held Philadelphia extruder that does its manufacturing in Greenwood, Del. Hyde President Richard Garthwaite would not disclose why his firm and Penn Fibre mutually agreed not to conclude a deal they had worked on for about 18 months. Penn Fibre President William Gies said in a news release that ``while joining forces appeared to offer many advantages, the situation and timing are not right for Hyde to pursue this acquisition further.'' Gies and other Penn Fibre officials were unavailable to elaborate.
Garthwaite said in a Jan. 22 telephone interview from Hyde's Grenloch head office that Penn Fibre's extrusion business would have fit well with Hyde's.
Garthwaite did not release sales figures for Hyde's or Penn Fibre's extrusion operations. Hyde also had $6.5 million in custom injection molding sales in 1994 at its Grenloch operation.
Schawk plans sale of infection unit
DES PLAINES, ILL. - Schawk Inc. plans to sell its Plastic Molded Concepts business unit to a management group headed by the unit's president.
Des Plaines-based Schawk announced the plan Jan. 16. The plastics group, in Eagle, Wis., specializes in custom injection molding of durable goods for industrial and health-care markets. Schawk said the sale will allow it to focus on its filtration and graphics businesses. Terms of the deal were not disclosed.
Harley-Davidson to divest molding unit
MISHAWAKA, IND. - A restructuring move at Harley-Davidson Motor Co., the Milwaukee-based motorcycle manufacturer, will lead to the spinoff of an Indiana injection molder.
HDC announced Jan. 22 that it will sell its Holiday Rambler Recreational Vehicle Division, and has retained an investment firm to explore the sale of Mishawaka-based B&B Molders, a subsidiary of Holiday Rambler. The motorcycle and parts manufacturer said selling Holiday Rambler will enable Harley to concentrate resources better on its core businesses.
Holiday Rambler, based in Wakarusa, Ind., makes commercial vehicles and vans through its Utilimaster Inc. subsidiary, also based in Wakarusa. Harley-Davidson said it wants to sell the Utilimaster and B&B units separately from Holiday Rambler.
Greg Dobrzykowski, national sales manager for B&B, said the proposed sale of the company will not affect shipments or deliveries of its products.
Ford plans parts plants in Thailand
BANGKOK, THAILAND-Ford Motor Co. plans to build two parts plants in Thailand, one of which would make plastic parts.
Ford announced Jan. 24 that it had asked the Thai government for approval to build a $30 million plant to make plastic, electrical and electronics components and a $23 million plant to make climate-control parts.
Construction of the plants could begin this year, with pro-duction starting in 1998, Ford said. Both plants will support a planned factory to produce Ford and Mazda pickup trucks.
George Lutz, managing director of Asia-Pacific operations for Ford's Automotive Components Division, said the factories might be built nearby the pickup plant, in Rayong province, 70 miles southeast of Bangkok. Lutz said the component factories will supply about $600 worth of parts for each vehicle.
Bayer may gian PET, PBT capacity
AKRON, OHIO - Bayer AG of Leverkusen, Germany, parent of Bayer Corp. of Pittsburgh, soon may acquire - in some fashion - PET and polybutylene terephthalate production capacity.
Peter Mueller, senior vice president for plastics marketing, said Jan. 22 at Plastics News' office in Akron that Bayer always is interested in strengthening its position in the production of raw materials it uses.
``We hope to improve our PET/PBT position and to be stronger there,'' he said.
Mueller said Bayer is forming plans, and may make an announcement within the next month about its intentions to acquire PET or PBT production or to form a venture with another firm that would ensure its supply of those resins. Bayer makes blends of polycarbonate/polyester resins under its Makroblend trade name. Mueller said such a move likely would affect Bayer in Europe before it affects North American markets.